Operative Results of Mitral Valve Repair and Replacement in Chronic Ischaemic Mitral Valve Regurgitation

Damian Gimpel1, Michael Cheung2, Levi Bassin3

  • 1School of Medicine Sydney, University of Notre Dame Australia, Sydney, NSW, Australia; Department of Cardiothoracic Surgery, The Prince of Wales Hospital, Sydney, NSW, Australia.

Abstract

Insights

Mitral valve repair and replacement for chronic ischaemic mitral regurgitation (IMR) show similar outcomes. Both procedures offer acceptable mortality and excellent postoperative results for IMR patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Ischaemic mitral regurgitation (IMR) significantly impacts patient morbidity and mortality.
  • Surgical options for IMR include isolated coronary artery bypass grafting (CABG) or combined with mitral valve intervention.
  • The optimal surgical strategy for the mitral valve in chronic IMR remains a subject of debate.

Purpose of the Study:

  • To compare early and late follow-up outcomes of mitral valve repair versus replacement in patients with chronic IMR.
  • To evaluate operative and echocardiographic results for both surgical approaches.

Main Methods:

  • A retrospective review of prospectively collected data from 119 patients undergoing mitral repair (n=101) or replacement (n=18) for chronic IMR.
  • Pre- and postoperative transthoracic echocardiograms were analyzed.
  • Long-term mortality data was obtained from the Australian National Death Index (NDI).

Main Results:

  • No significant differences in cardiopulmonary bypass time, cross-clamp time, ICU stay, or discharge time between repair and replacement groups.
  • The replacement cohort had higher preoperative pulmonary artery pressures and greater IMR severity.
  • Five-year survival was 85% for repair and 77.8% for replacement; postoperative mitral regurgitation was mild or trivial in most patients in both groups.

Conclusions:

  • Both mitral valve repair and replacement for chronic IMR demonstrate acceptable mortality and reintervention rates.
  • Excellent postoperative echocardiographic outcomes were observed for both procedures.
  • Further research is needed on quality of life and predictive factors for optimal treatment selection in IMR.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
187
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
221
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
262
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
165
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
239
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
254